ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

JMO JPMorg.Oseas It

220.00
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
JPMorg.Oseas It LSE:JMO London Ordinary Share GB00BYMKY695 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 220.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

JPMorgan Global Growth & Income PLC Results analysis from Kepler Trust Intelligence

05/03/2021 3:21pm

RNS Non-Regulatory


TIDMJGGI

JPMorgan Global Growth & Income PLC

05 March 2021

JPMorgan Global Growth & Income (JGGI)

05/03/2021

Results analysis from Kepler Trust Intelligence

-- Today JGGI released its interim results for the period ending 31 December 2020. Over the six months the trust delivered NAV total returns of 15.4%, while the price total return to shareholders including dividends reinvested was 17.1%.

-- At the current share price (05/03/21) JGGI yields 3.4%, and two quarterly dividends were paid during the period equating to 6.58p. The board anticipates a full year dividend of 13.16p, which is nearly 1% higher relative to the previous year.

-- The managers believe we are at the start of a new market cycle. They believe that the recovery is not a short-term event and will take multiple years, however they are positive on the outlook and have reflected this in their portfolio positioning.

Kepler view

JPMorgan Global Growth & Income (JGGI) has delivered another strong set of results for investors, demonstrating the managers' ability to outperform the benchmark. In NAV terms The trust has now outperformed its benchmark by a margin of 1.5%, 6.6% and 1.9% over one year, five years and ten years respectively.

Looking ahead, while mass vaccinations will take time, and there is the possibility of complications, the return to some level of normality should result in a global economic recovery and significant uptick in corporate earnings. JGGI stands to benefit from this, with the managers shifting the portfolio away from stocks that have done particularly well in the pandemic and towards cyclical companies that should benefit from an economic rebound.

JGGI's income is directly tied to its NAV growth which is paid out in part from capital with a target pay-out of 4% of NAV as at the previous financial year-end. This allows JGGI to offer a different risk/return profile to that of its peers, freed from the more typical high-income names.

The managers will continue to focus on their strengths in the year ahead, which involves identifying structural trends, thinking long term, and finding great companies in which to invest. The trust currently (05/03/21) trades at a premium of 2.6%.

CLICK HERE TO READ THE FULL REPORT

Visit http://www.trustintelligence.co.uk/investor for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 9/10 Savile Row, London W1S 3PF with registered number OC334771.

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word "Reach" in the source column of the News Explorer pages of London Stock Exchange's website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRADKPBDPBKDONK

(END) Dow Jones Newswires

March 05, 2021 10:21 ET (15:21 GMT)

1 Year JP Morgan Fleming Overseas It Chart

1 Year JP Morgan Fleming Overseas It Chart

1 Month JP Morgan Fleming Overseas It Chart

1 Month JP Morgan Fleming Overseas It Chart